Israeli bio-pharmceutical startup ChemomAb snags $10 mln
ChemomAb, an Israeli bio-pharmaceutical start-up, has closed $10 million in funding. OrbiMed Israel and Peter Thiel led the round with participation from SBI Japan-Israel Innovation Fund and Milestone Venture.
4 December 2017•1 min read
